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Abstract
Children suffering from left atrioventricular valve (LAVV) disease not amenable to repair represent a signiﬁcant challenge. The results of
surgical reconstruction are not optimal. Valve replacement as an alternative is associated with poor results. The surgical-hybrid approach
with implantation of a stented biological valve (bovine jugular vein graft, Melody® valve) seems to represent a new therapeutic option.
Here we demonstrate our case, the consideration and the approach to extreme clinical ﬁndings in a small child. We describe a simpliﬁed
surgical-hybrid Melody valve implantation in a LAVV position. The technique of implantation is relatively simple and the immediate post-
operative result very good.
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INTRODUCTION
Children suffering from left atrioventricular valve (LAVV) disease
represent a signiﬁcant challenge. Surgical implantation of a Melody®
(Medtronic, Minneapolis, MN, USA) valve in the mitral position re-
cently described by Abdullah et al. [1] and Quiñonez et al. [2] appears
to be a promising option.
We describe a simpliﬁed surgical/hybrid implantation of a
Melody® valve in the mitral position in a small child suffering from
stenosis, 2 years after repair of a complete AV canal defect.
CASE REPORT
A 2.5-year-old boy was admitted to our hospital with a severe
LAVV stenosis nearly 2 years after a satisfactory correction of a
complete AV canal which coincided with the diagnosis of acute
myeloid leukaemia.
The aetiology of the stenosis was multifactorial and attributed to:
hypoplastic annulus, skewed commissures, thickened anterior leaﬂet
and extreme subvalvular crowding. The need for the relief of sten-
osis became more urgent since chemotherapy for acute myeloid
leukaemia was expected to lead to signiﬁcant volume overload.
Percutaneous balloon valvuloplasty resulted only in transient
improvement. A surgical repair was performed, which included
extensive commissurotomy, papillary muscle and chordal splitting,
partial resection of the redundant thickened leaﬂet as well as
lengthening of the anterior leaﬂet with autologous pericardium.
Intraoperatively, the annulus measured around 12 mm (z-score: −2.3).
The little improvement after surgical reconstruction was short-
lived with the mean gradient quickly rising to the preoperative
level.
A second reoperation was performed after 3 weeks. The LAVV
was accessed trans-septally. The incision across the anteroseptal
tricuspid valve commissure was extended across the ventricular
septal defect patch. Replacement with a Melody® valve was
undertaken. The original 3-cm long Melody® valve was shor-
tened to 2 cm by bending the proximal and distal rows of
prongs (Fig. 1A and B). The Melody® valve was crimped (12 mm
diameter) and annular ﬁxation was achieved using 10 single 5-0
polypropylene stitches, most of them hooking the wired stent
(Fig. 1C). Simple interrupted sutures were placed to facilitate a
later dilatation. Part of the subvalvular apparatus abutting the
anterior commissure was detached, while the complete anter-
ior leaﬂet and the corresponding subvalvular apparatus were
retained. With this technique, equal protrusion of the Melody®
valve into the left atrium and ventricle was ensured. Further sta-
bilization was achieved by progressive dilatation using a 14- and
16-mm balloon. Therefore, any kind of further anchorage of the
stented valve (pericardial sewing cuff or a distal ﬁxation to the
left ventricular lateral wall), as described previously [1, 2], was not
necessary. The trans-septal opening was reconstructed using a
generous-sized xenopericardial patch to enlarge the left atrium
and to ensure an unobstructed inﬂow. Intraoperative echocardi-
ography showed a good result without paravalvular leakage, with
a minimal central jet (Fig. 1D). In our ﬁrst case, the clamping†The ﬁrst two authors share the ﬁrst authorship equally.
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time was 150 min. This was due to the revision of one ﬁxation
suture, which had affected the valve motion. Avoiding this and
considering that this was our ﬁrst case, the operation time will be
signiﬁcantly shorter in the future.
There was no obstruction to the pulmonary venous ﬂow. The
invasive blood pressure measurements of the left ventricle and
the aorta revealed a gradient of <10 mmHg. Postoperative trans-
thoracic echo did demonstrate gradients up to 40 mmHg, which
reduced on swapping adrenaline with noradrenaline (reducing
the hypercontractility and increasing afterload). In the subsequent
course during the ﬁrst postoperative week, the left ventricular
outﬂow tract gradient stabilized at 10 mmHg. The mean gradient
across the Melody® valve remained <5 mmHg and the previous
pulmonary venous congestion resolved completely.
Therapeutic heparinization was instituted. Because of spon-
taneous thrombocytopenia related to the myeloid leukaemia,
use of an antiplatelet agent was avoided. Chemotherapy could
be initialized 3 weeks after valve replacement without any hae-
modynamic impairment. Repeated echocardiographic assess-
ments always revealed low Doppler gradients without any relevant
regurgitation.
DISCUSSION
The surgical treatment of mitral valve stenosis in paediatric
patients remains very challenging. Understanding the mechanism
is the key to a successful reconstruction. A hypoplastic annulus
does not have dependable solutions. While the surgical options
are limited, balloon valvuloplasty is also palliative. Although
improvements may be achieved acutely, there is a high risk of
restenosis or severe mitral regurgitation [3].
Since the chances of successful reconstruction or balloon valvu-
loplasty are uncertain, valve replacement remains the ultima ratio.
There exist, however, few options for valve replacement in small
children [4]. Mechanical valves are very durable, but need lifelong
anticoagulation. Biological valve substitutes such as homograft or
xenograft are difﬁcult to get in small sizes (14 or 16 mm), do not
grow and degenerate/calcify quickly.
Percutaneous pulmonary valve replacement using stented
valves like the Melody® valve or the Edwards SAPIEN® pulmonic
valve (Edwards Lifesciences, LLC, Irvine CA, USA) has become an
established alternative to surgery [5]. Hence, it seems logical that a
stented valve might also be placed in the mitral position, even in
children.
The Melody® valve offers many advantages: the circular stent
provides a large effective oriﬁce area and hopefully protects from
pannus ingrowth. Additionally, the bovine jugular vein leaﬂet tissue
is thin and pliable, which is suitable for the low cardiac output in
infants. And most importantly, it could be redilatated correspond-
ing to the growth of the child via a minimally invasive approach.
Our technique is a step forwards in standardizing and sim-
plifying the Melody® valve implantation procedure in a hybrid-
surgical setting. In contrast to the reported Boston group approach,
our technique avoided resection of the subvalvular left ventricular
apparatus which helped to position and stabilize the valve into
the correct inﬂow position, also making a distal ﬁxation dispens-
able. Furthermore, we did not use an additional pericardial
Figure 1: (A) Melody® transcatheter pulmonary valve. (B) Preparation of the Melody® valve. (C) Fixation of the Melody® valve. (D) Intraoperative transoesophageal
echocardiography.
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sewing ring to prevent paravalvular leaks. We experienced that
the remaining valvular tissue and the intraoperative redilatation
ensured a complete expansion and a leak-proof circular anchoring
without paravalvular leakage.
We avoided any resection of stent struts which may inﬂuence
the radial and longitudinal stability. The bending of the proximal
and distal rows of the struts reduces the valve proﬁle and prevents
atrial inﬂow and LVOT obstruction.
While hybrid-surgical implantation of a Melody® valve in the
mitral position is an elegant option that can be safely performed
and reproduced, the till date published experiences remain anec-
dotal. In view of this, the indications, technique, impact on pul-
monary venous ﬂow, impingement on the LVOT, anticoagulation
regimen and long-term durability of the Melody® valve in systemic
circulation are questions which await answers pending greater
experience.
Conﬂict of interest: Oliver Kretschmar serves as a Melody proctor.
REFERENCES
[1] Abdullah I, Ramirez FB, McElhinney DB, Lock JE, del Nido PJ, Emani S.
Modiﬁcation of a stented bovine jugular vein conduit (melody valve) for
surgical mitral valve replacement. Ann Thorac Surg 2012;94:e97–8.
[2] Quiñonez LG, Breitbart R, Tworetsky W, Lock JE, Marshall AC, Emani SM.
Stented bovine jugular vein graft (Melody valve) for surgical mitral valve
replacement in infants and children. J Thorac Cardiovasc Surg 2014;148:
1443–9.
[3] McElhinney DB, Sherwood MC, Keane JF, del Nido PJ, Almond C, Lock JE.
Current management of severe congenital mitral stenosis: outcomes of
transcatheter and surgical therapy in 108 infants and children. Circulation
2005;112:707–14.
[4] Lamberti JJ, Kriett JM. Mitral/systemic atrioventricular valve repair in con-
genital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg
Annu 2007;10:94–100.
[5] Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D et al.
Percutaneous replacement of pulmonary valve in a right-ventricle to
pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;
356:1403–5.
M. Hofmann et al. / European Journal of Cardio-Thoracic Surgery928
